A. Bilici Et Al. , "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?," JOURNAL OF BUON , vol.17, no.3, pp.502-507, 2012
Bilici, A. Et Al. 2012. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?. JOURNAL OF BUON , vol.17, no.3 , 502-507.
Bilici, A., Yapici, H. S., Ercan, S., Seker, M., Ustaalioglu, B. B. O., Salman, T., ... Orcun, A.(2012). The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?. JOURNAL OF BUON , vol.17, no.3, 502-507.
Bilici, A. Et Al. "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?," JOURNAL OF BUON , vol.17, no.3, 502-507, 2012
Bilici, A. Et Al. "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?." JOURNAL OF BUON , vol.17, no.3, pp.502-507, 2012
Bilici, A. Et Al. (2012) . "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?." JOURNAL OF BUON , vol.17, no.3, pp.502-507.
@article{article, author={A. Bilici Et Al. }, title={The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?}, journal={JOURNAL OF BUON}, year=2012, pages={502-507} }